NCT02264886View on ClinicalTrials.gov

Adaptive MRI-Guided SBRT for Unresectable Primary or Oligometastatic Central Thorax and Abdominal Malignancies

PHASE1CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

January 31, 2015

Primary Completion Date

June 30, 2016

Study Completion Date

December 31, 2016

Conditions
Central Thorax CancerLiver CancerNon-Liver Abdominal Cancer
Interventions
RADIATION

MRI-guided stereotactive body radiation therapy

Trial Locations (1)

63110

Washington University School of Medicine, St Louis

All Listed Sponsors
lead

Washington University School of Medicine

OTHER

NCT02264886 - Adaptive MRI-Guided SBRT for Unresectable Primary or Oligometastatic Central Thorax and Abdominal Malignancies | Biotech Hunter | Biotech Hunter